You are here

China drugmaker in US$764m IPO

[HONG KONG] Luye Pharma Group, a Chinese drugmaker backed by Singapore's sovereign wealth fund, and the company's owners are poised to raise US$764 million from a Hong Kong initial public offering, people with knowledge of the matter said.

The company, based in eastern China's Yantai city...

Market voices on: